1. Nguyen S, Hojjati M. Review of current therapies for secondary hypertrophic pulmonary osteoarthropathy. Clin Rheumatol. 2011; 30:7–13.
Article
2. Shim YW, Suh JS. Primary hypertrophic osteoarthropathy accompanied by Crohn's disease: a case report. Yonsei Med J. 1997; 38:319–322.
Article
3. Yao Q, Altman RD, Brahn E. Periostitis and hypertrophic pulmonary osteoarthropathy: report of 2 cases and review of the literature. Semin Arthritis Rheum. 2009; 38:458–466.
Article
4. Kim TH, Lee HH, Chung SH, et al. Complication of Crohn's disease on the vulva treated as a Bartholin's gland abscess: a case report. Korean J Obstet Gynecol. 2010; 53:657–660.
Article
5. Neale G, Kelsall AR, Doyle FH. Crohn's disease and diffuse symmetrical periostitis. Gut. 1968; 9:383–387.
Article
6. Kozak KR, Milne GL, Morrow JD, et al. Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2. Nat Clin Pract Rheumatol. 2006; 2:452–456.
Article
7. Johnson JC, Schmidt CR, Shrubsole MJ, et al. Urine PGE-M: a metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Clin Gastroenterol Hepatol. 2006; 4:1358–1365.
Article
8. Dickinson CJ, Martin JF. Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet. 1987; 2:1434–1435.
Article
9. Atkinson S, Fox SB. Vascular endothelial growth factor (VEGF)-A and platelet-derived growth factor (PDGF) play a central role in the pathogenesis of digital clubbing. J Pathol. 2004; 203:721–728.
Article
10. Angel-Moreno Maroto A, Martínez-Quintana E, Suárez-Castellano L, et al. Painful hypertrophic osteoarthropathy successfully treated with octreotide. The pathogenetic role of vascular endothelial growth factor (VEGF). Rheumatology (Oxford). 2005; 44:1326–1327.
Article
11. Jayakar BA, Abelson AG, Yao Q. Treatment of hypertrophic osteoarthropathy with zoledronic acid: case report and review of the literature. Semin Arthritis Rheum. 2011; 41:291–296.
Article